Humanity is living in an interesting age, where scientists can finally start manipulating the human genome in ways that were not possible before due to CRISPR. Many have even hypothesized that through these amazing gene-editing tool, humans could become stronger, smarter, and all around better. Unfortunately, it could also lead to class warfare, an expert on genetics warns.
Dr. David King is a molecular biologist and is the founder of the watchdog group Human Genetics Alert. In a recent opinion piece published on The Guardian, Dr. King throws some cautious words at readers, warning them about the dangers of a blind race towards medical progress at the cost of everything else.
He is particularly keen on cautioning the public about genetic manipulation, especially when it no longer has anything to do with treating actual conditions. Dr. King explains that there are already plenty of ways to address genetic conditions among infants via early testing.
“Scientists who started their careers hoping to treat sick people and prevent suffering are now earning millions of dollars creating drugs to “enhance cognitive performance” or performing cosmetic surgery. We already have consumer eugenics in the US egg donor market, where ordinary working-class women get paid $5,000 for their eggs while tall, beautiful Ivy League students get $50,000. The free market effectively results in eugenics,” Dr. King writes.
Of course, for every person that shares Dr. King’s concerns, there are those who say that being able to tamper with genetic traits in babies is still a long way off. A researcher from Toronto’s Hospital for Sick Children, Dr. Janet Rossant said as much in another article published by The Guardian. According to her, designer babies are still not in the veil of reality as of right now.
“We are still a long way from serious consideration of using gene editing to enhance traits in babies,” Dr. Rossant explained. “We don’t understand the genetic basis of many of the human traits that might be targets for enhancement.”


SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
China vs. NASA: The New Moon Race and What's at Stake by 2030
Trump Administration Releases New UFO Files and Apollo Mission Records
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tabletop particle accelerator could transform medicine and materials science 



